Reason for withdrawal from publication
This review has been withdrawn from The Cochrane Libaray, as of issue 3, 2004. The lead author reports that the reviewers could no longer work towards updating it. Two main issues combined resulted in this decision to withdraw the review: ‐ a lack of funding to update reviews; ‐ unpublished data used in the original review were inaccessible to both reviewers, and anyone else wishing to update this review, thereby making it impossible to cite all data used in subsequent updates.
The editorial group responsible for this previously published document have withdrawn it from publication.
Feedback
Typographical error
Summary
There is a typographical error in the Reviewer's Conclusions section where investigated drugs are listed as dipyridamole, palmitate, ICI 130, 685, Impulsin and Pleconaril. Earlier the article refers to Impulsin (palmitate) implying that palmitate is actually the generic name for Impulsin. Could the reviewers please correct whichever part is wrong?
I certify that I have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter of my criticisms.
Reply
Many thanks for pointing out this error. It has now been corrected.
Contributors
Comment by Dr Stephen Scholem (General practitioner).
What's new
| Date | Event | Description |
|---|---|---|
| 28 March 2008 | Amended | Converted to new review format. |
History
Protocol first published: Issue 4, 2000 Review first published: Issue 3, 2001
| Date | Event | Description |
|---|---|---|
| 29 May 2001 | New citation required and conclusions have changed | Substantive amendment |
Sources of support
Internal sources
NHS Research and Development Programme, UK.
Health Reviews Ltd, UK.
External sources
BMA HC Roscoe Fund, UK.
Withdrawn from publication for reasons stated in the review